- Home
- DSGX vs TECH Comparison
DSGX vs TECH Comparison
Compare DSGX & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGX
- TECH
- Stock Information
- Founded
- DSGX 1981
- TECH 1976
- Country
- DSGX Canada
- TECH United States
- Employees
- DSGX N/A
- TECH N/A
- Industry
- DSGX Computer Software: Prepackaged Software
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DSGX Technology
- TECH Health Care
- Exchange
- DSGX Nasdaq
- TECH Nasdaq
- Market Cap
- DSGX 10.2B
- TECH 11.3B
- IPO Year
- DSGX 1999
- TECH 1989
- Fundamental
- Price
- DSGX $114.85
- TECH $71.41
- Analyst Decision
- DSGX Buy
- TECH Buy
- Analyst Count
- DSGX 12
- TECH 8
- Target Price
- DSGX $115.17
- TECH $82.00
- AVG Volume (30 Days)
- DSGX 244.3K
- TECH 750.3K
- Earning Date
- DSGX 12-03-2024
- TECH 01-30-2025
- Dividend Yield
- DSGX N/A
- TECH 0.45%
- EPS Growth
- DSGX 20.62
- TECH N/A
- EPS
- DSGX 1.58
- TECH 0.95
- Revenue
- DSGX $631,755,000.00
- TECH $1,171,583,000.00
- Revenue This Year
- DSGX $13.75
- TECH $7.67
- Revenue Next Year
- DSGX $11.07
- TECH $9.38
- P/E Ratio
- DSGX $74.05
- TECH $75.66
- Revenue Growth
- DSGX 14.90
- TECH 2.41
- 52 Week Low
- DSGX $79.21
- TECH $61.16
- 52 Week High
- DSGX $122.88
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- DSGX 45.68
- TECH 40.82
- Support Level
- DSGX $118.99
- TECH $74.41
- Resistance Level
- DSGX $122.55
- TECH $77.62
- Average True Range (ATR)
- DSGX 2.50
- TECH 2.29
- MACD
- DSGX -0.61
- TECH -0.26
- Stochastic Oscillator
- DSGX 1.35
- TECH 2.71
About DSGX Descartes Systems Group Inc. (The)
Descartes Systems Group provides a software solution that allows users in the shipping industry to communicate with one another. Its core product is the Global Logistics Network, which is best understood as transaction-driven. Descartes charges clients to send/receive messages, data, and documents on the GLN. Customers typically contract for a monthly minimum over a multiyear period. The GLN platform allows Descartes to upsell additional software modules as well, typically provided via a software-as-a-service model.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.